Fuyuan Medicine: Left thyroid hormone sodium tablets obtained drug registration certificate.

Fuyuan Pharmaceutical announced that the company has recently received the Drug Registration Certificate for Sodium Levothyroxine Tablets issued by the National Medical Products Administration, approving the production of the drug. Sodium Levothyroxine Tablets were developed by Merck and was first approved for sale in France in June 1980. The company received a notice of acceptance for declaration on March 27, 2024, and as of the date of this announcement, the company has accumulated research and development investment of 7.57 million yuan for the drug.